-
2
-
-
84945146392
-
Prostate cancer
-
pii: S0140-6736(14)61947-4
-
G. Attard, C. Parker, R.A. Eeles, F. Schröder, S.A. Tomlins, I. Tannock, and et al. Prostate cancer Lancet 2015 pii: S0140-6736(14)61947-4
-
(2015)
Lancet
-
-
Attard, G.1
Parker, C.2
Eeles, R.A.3
Schröder, F.4
Tomlins, S.A.5
Tannock, I.6
-
3
-
-
84940469697
-
Management of patients with advanced prostate cancer: Recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
-
S. Gillessen, A. Omlin, G. Attard, J.S. de Bono, E. Efstathiou, K. Fizazi, and et al. Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015 Ann Oncol 26 2015 1589 1604
-
(2015)
Ann Oncol
, vol.26
, pp. 1589-1604
-
-
Gillessen, S.1
Omlin, A.2
Attard, G.3
De Bono, J.S.4
Efstathiou, E.5
Fizazi, K.6
-
4
-
-
84942982616
-
Bone-related parameters are the main prognostic factors for overall survival in men with bone metastases from castration-resistant prostate cancer
-
K. Fizazi, C. Massard, M. Smith, M. Rader, J. Brown, P. Milecki, and et al. Bone-related parameters are the main prognostic factors for overall survival in men with bone metastases from castration-resistant prostate cancer Eur Urol 2014 10.1016/j.eururo.2014.10.001
-
(2014)
Eur Urol
-
-
Fizazi, K.1
Massard, C.2
Smith, M.3
Rader, M.4
Brown, J.5
Milecki, P.6
-
5
-
-
74949112755
-
Prediction of survival following first-line chemotherapy in men with castration-resistant metastatic prostate cancer
-
A.J. Armstrong, E. Garrett-Mayer, R. de Wit, I. Tannock, and M. Eisenberger Prediction of survival following first-line chemotherapy in men with castration-resistant metastatic prostate cancer Clin Cancer Res 16 2010 203 211
-
(2010)
Clin Cancer Res
, vol.16
, pp. 203-211
-
-
Armstrong, A.J.1
Garrett-Mayer, E.2
De Wit, R.3
Tannock, I.4
Eisenberger, M.5
-
6
-
-
84898823273
-
Updated prognostic model for predicting overall survival in first-line chemotherapy for patients with metastatic castration-resistant prostate cancer
-
S. Halabi, C.Y. Lin, W.K. Kelly, K.S. Fizazi, J.W. Moul, E.B. Kaplan, and et al. Updated prognostic model for predicting overall survival in first-line chemotherapy for patients with metastatic castration-resistant prostate cancer J Clin Oncol 32 2014 671 677
-
(2014)
J Clin Oncol
, vol.32
, pp. 671-677
-
-
Halabi, S.1
Lin, C.Y.2
Kelly, W.K.3
Fizazi, K.S.4
Moul, J.W.5
Kaplan, E.B.6
-
7
-
-
84866595620
-
Sarcopenia during androgen-deprivation therapy for prostate cancer
-
M.R. Smith, F. Saad, B. Egerdie, P.R. Sieber, T.L. Tammela, C. Ke, and et al. Sarcopenia during androgen-deprivation therapy for prostate cancer J Clin Oncol 30 2012 3271 3276
-
(2012)
J Clin Oncol
, vol.30
, pp. 3271-3276
-
-
Smith, M.R.1
Saad, F.2
Egerdie, B.3
Sieber, P.R.4
Tammela, T.L.5
Ke, C.6
-
8
-
-
0037464510
-
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
-
E.E. Calle, C. Rodriguez, K. Walker-Thurmond, and M.J. Thun Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults N Engl J Med 348 2003 1625 1638
-
(2003)
N Engl J Med
, vol.348
, pp. 1625-1638
-
-
Calle, E.E.1
Rodriguez, C.2
Walker-Thurmond, K.3
Thun, M.J.4
-
9
-
-
0034899087
-
Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States
-
C. Rodriguez, A.V. Patel, E.E. Calle, E.J. Jacobs, A. Chao, and M.J. Thun Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States Cancer Epidemiol Biomarkers Prev 10 2001 345 353
-
(2001)
Cancer Epidemiol Biomarkers Prev
, vol.10
, pp. 345-353
-
-
Rodriguez, C.1
Patel, A.V.2
Calle, E.E.3
Jacobs, E.J.4
Chao, A.5
Thun, M.J.6
-
10
-
-
34648825008
-
Inverse correlation between body mass index and clinical outcomes in men with advanced castration-recurrent prostate cancer
-
S. Halabi, S.S. Ou, N.J. Vogelzang, and E.J. Small Inverse correlation between body mass index and clinical outcomes in men with advanced castration-recurrent prostate cancer Cancer 110 2007 1478 1484
-
(2007)
Cancer
, vol.110
, pp. 1478-1484
-
-
Halabi, S.1
Ou, S.S.2
Vogelzang, N.J.3
Small, E.J.4
-
11
-
-
45849124963
-
Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study
-
C.M. Prado, J.R. Lieffers, L.J. McCargar, T. Reiman, M.B. Sawyer, L. Martin, and et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study Lancet Oncol 9 2008 629 635
-
(2008)
Lancet Oncol
, vol.9
, pp. 629-635
-
-
Prado, C.M.1
Lieffers, J.R.2
McCargar, L.J.3
Reiman, T.4
Sawyer, M.B.5
Martin, L.6
-
12
-
-
72549086598
-
Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer
-
B.H. Tan, L.A. Birdsell, L. Martin, V.E. Baracos, and K.C. Fearon Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer Clin Cancer Res 15 2009 6973 6979
-
(2009)
Clin Cancer Res
, vol.15
, pp. 6973-6979
-
-
Tan, B.H.1
Birdsell, L.A.2
Martin, L.3
Baracos, V.E.4
Fearon, K.C.5
-
13
-
-
84904295562
-
Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immune chemotherapy
-
H. Lanic, J. Kraut-Tauzia, R. Modzelewski, F. Clatot, S. Mareschal, J.M. Picquenot, and et al. Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immune chemotherapy Leuk Lymphoma 55 2014 817 823
-
(2014)
Leuk Lymphoma
, vol.55
, pp. 817-823
-
-
Lanic, H.1
Kraut-Tauzia, J.2
Modzelewski, R.3
Clatot, F.4
Mareschal, S.5
Picquenot, J.M.6
-
14
-
-
82355190591
-
Does obesity influence the prognosis of metastatic renal cell carcinoma in patients treated with vascular endothelial growth factor-targeted therapy?
-
S. Steffens, V. Grunwald, K.I. Ringe, C. Seidel, H. Eggers, M. Schrader, and et al. Does obesity influence the prognosis of metastatic renal cell carcinoma in patients treated with vascular endothelial growth factor-targeted therapy? Oncologist 16 2011 1565 1571
-
(2011)
Oncologist
, vol.16
, pp. 1565-1571
-
-
Steffens, S.1
Grunwald, V.2
Ringe, K.I.3
Seidel, C.4
Eggers, H.5
Schrader, M.6
-
15
-
-
77955703763
-
Influence of visceral obesity on oncologic outcome in patients with renal cell carcinoma
-
Y. Naya, S. Zenbutsu, K. Araki, K. Nakamura, M. Kobayashi, S. Kamijima, and et al. Influence of visceral obesity on oncologic outcome in patients with renal cell carcinoma Urol Int 85 2010 30 36
-
(2010)
Urol Int
, vol.85
, pp. 30-36
-
-
Naya, Y.1
Zenbutsu, S.2
Araki, K.3
Nakamura, K.4
Kobayashi, M.5
Kamijima, S.6
-
16
-
-
79952581004
-
Visceral fat area as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with antiangiogenic agents
-
S. Ladoire, F. Bonnetain, M. Gauthier, S. Zanetta, J.M. Petit, S. Guiu, and et al. Visceral fat area as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with antiangiogenic agents Oncologist 16 2011 71 81
-
(2011)
Oncologist
, vol.16
, pp. 71-81
-
-
Ladoire, S.1
Bonnetain, F.2
Gauthier, M.3
Zanetta, S.4
Petit, J.M.5
Guiu, S.6
-
17
-
-
84866948935
-
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: Final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
-
K. Fizazi, H.I. Scher, A. Molina, C.J. Logothetis, K.N. Chi, R.J. Jones, and et al. Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study Lancet Oncol 13 2012 983 992
-
(2012)
Lancet Oncol
, vol.13
, pp. 983-992
-
-
Fizazi, K.1
Scher, H.I.2
Molina, A.3
Logothetis, C.J.4
Chi, K.N.5
Jones, R.J.6
-
18
-
-
84921846878
-
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): Final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
-
C.J. Ryan, M.R. Smith, K. Fizazi, F. Saad, P.F. Mulders, C.N. Sternberg, and et al. Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study Lancet Oncol 16 2015 152 160
-
(2015)
Lancet Oncol
, vol.16
, pp. 152-160
-
-
Ryan, C.J.1
Smith, M.R.2
Fizazi, K.3
Saad, F.4
Mulders, P.F.5
Sternberg, C.N.6
-
19
-
-
84856774377
-
Clinical and biochemical consequences of CYP17A1 inhibition with abiraterone given with and without exogenous glucocorticoids in castrate men with advanced prostate cancer
-
G. Attard, A.H. Reid, R.J. Auchus, B.A. Hughes, A.M. Cassidy, E. Thompson, and et al. Clinical and biochemical consequences of CYP17A1 inhibition with abiraterone given with and without exogenous glucocorticoids in castrate men with advanced prostate cancer J Clin Endocrinol Metab 97 2012 507 516
-
(2012)
J Clin Endocrinol Metab
, vol.97
, pp. 507-516
-
-
Attard, G.1
Reid, A.H.2
Auchus, R.J.3
Hughes, B.A.4
Cassidy, A.M.5
Thompson, E.6
-
20
-
-
84908450155
-
Enzalutamide in metastatic prostate cancer before chemotherapy
-
T.M. Beer, A.J. Armstrong, D.E. Rathkopf, Y. Loriot, C.N. Sternberg, and et al. Enzalutamide in metastatic prostate cancer before chemotherapy N Engl J Med 371 2014 424 433
-
(2014)
N Engl J Med
, vol.371
, pp. 424-433
-
-
Beer, T.M.1
Armstrong, A.J.2
Rathkopf, D.E.3
Loriot, Y.4
Sternberg, C.N.5
-
21
-
-
84866770294
-
Increased survival with enzalutamide in prostate cancer after chemotherapy
-
H.I. Scher, K. Fizazi, F. Saad, M.E. Taplin, C.N. Sternberg, K. Miller, and et al. Increased survival with enzalutamide in prostate cancer after chemotherapy N Engl J Med 367 2012 1187 1197
-
(2012)
N Engl J Med
, vol.367
, pp. 1187-1197
-
-
Scher, H.I.1
Fizazi, K.2
Saad, F.3
Taplin, M.E.4
Sternberg, C.N.5
Miller, K.6
-
22
-
-
53649107585
-
A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care
-
M. Mourtzakis, C.M. Prado, J.R. Lieffers, T. Reiman, L.J. McCargar, and V.E. Baracos A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care Appl Physiol Nutr Metab 33 2008 997 1006
-
(2008)
Appl Physiol Nutr Metab
, vol.33
, pp. 997-1006
-
-
Mourtzakis, M.1
Prado, C.M.2
Lieffers, J.R.3
Reiman, T.4
McCargar, L.J.5
Baracos, V.E.6
-
23
-
-
9244242572
-
Total body skeletal muscle and adipose tissue volumes: Estimation from a single abdominal cross-sectional image
-
W. Shen, M. Punyanitya, Z. Wang, D. Gallagher, M.P. St-Onge, J. Albu, and et al. Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image J Appl Physiol 97 2004 2333 2338
-
(2004)
J Appl Physiol
, vol.97
, pp. 2333-2338
-
-
Shen, W.1
Punyanitya, M.2
Wang, Z.3
Gallagher, D.4
St-Onge, M.P.5
Albu, J.6
-
24
-
-
84876581806
-
Cancer cachexia in the age of obesity: Skeletal muscle depletion is a powerful prognostic factor, independent of body mass index
-
L. Martin, L. Birdsell, N. Macdonald, T. Reiman, M.T. Clandinin, L.J. McCargar, and et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index J Clin Oncol 31 2013 1539 1547
-
(2013)
J Clin Oncol
, vol.31
, pp. 1539-1547
-
-
Martin, L.1
Birdsell, L.2
Macdonald, N.3
Reiman, T.4
Clandinin, M.T.5
McCargar, L.J.6
-
25
-
-
0029851283
-
A note on quantifying follow-up in studies of failure time
-
M. Schemper, and T.L. Smith A note on quantifying follow-up in studies of failure time Control Clin Trials 17 1996 343 346
-
(1996)
Control Clin Trials
, vol.17
, pp. 343-346
-
-
Schemper, M.1
Smith, T.L.2
-
26
-
-
84861543054
-
Reporting recommendations for tumor marker prognostic studies (REMARK): Explanation and elaboration
-
D.G. Altman, L.M. McShane, W. Sauerbrei, and S.E. Taube Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration PLoS Med 9 5 2012 e1001216 10.1371 /journal.pmed.1001216
-
(2012)
PLoS Med
, vol.9
, Issue.5
, pp. e1001216
-
-
Altman, D.G.1
McShane, L.M.2
Sauerbrei, W.3
Taube, S.E.4
-
27
-
-
84921968868
-
Obesity and long-term survival after radical prostatectomy
-
H.J. Chalfin, S.B. Lee, B.C. Jeong, S.J. Freedland, H. Alai, Z. Feng, and et al. Obesity and long-term survival after radical prostatectomy J Urol 192 2014 1100 1104
-
(2014)
J Urol
, vol.192
, pp. 1100-1104
-
-
Chalfin, H.J.1
Lee, S.B.2
Jeong, B.C.3
Freedland, S.J.4
Alai, H.5
Feng, Z.6
-
29
-
-
34250633536
-
Risk factor paradox in wasting diseases
-
K. Kalantar-Zadeh, T.B. Horwich, A. Oreopoulos, C.P. Kovesdy, H. Younessi, S.D. Anker, and et al. Risk factor paradox in wasting diseases Curr Opin Clin Nutr Metab Care 10 2007 433 442
-
(2007)
Curr Opin Clin Nutr Metab Care
, vol.10
, pp. 433-442
-
-
Kalantar-Zadeh, K.1
Horwich, T.B.2
Oreopoulos, A.3
Kovesdy, C.P.4
Younessi, H.5
Anker, S.D.6
-
30
-
-
84902543625
-
Prognostic impact of fat tissue loss and cachexia assessed by computed tomography scan in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy
-
V. Camus, H. Lanic, J. Kraut, R. Modzelewski, F. Clatot, J.M. Pisquenot, and et al. Prognostic impact of fat tissue loss and cachexia assessed by computed tomography scan in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy Eur J Haematol 93 2014 9 18
-
(2014)
Eur J Haematol
, vol.93
, pp. 9-18
-
-
Camus, V.1
Lanic, H.2
Kraut, J.3
Modzelewski, R.4
Clatot, F.5
Pisquenot, J.M.6
-
31
-
-
42149118391
-
Regulation of adipose tissue metabolism in cancer cachexia
-
C. Bing, and P. Trayhurn Regulation of adipose tissue metabolism in cancer cachexia Curr Opin Clin Nutr Metab Care 11 2008 201 207
-
(2008)
Curr Opin Clin Nutr Metab Care
, vol.11
, pp. 201-207
-
-
Bing, C.1
Trayhurn, P.2
-
32
-
-
34347242117
-
Mechanism of increased lipolysis in cancer cachexia
-
T. Agustsson, M. Rydén, J. Hoffstedt, V. van Harmelen, A. Dicker, J. Laurencikiene, and et al. Mechanism of increased lipolysis in cancer cachexia Cancer Res 67 2007 5531 5537
-
(2007)
Cancer Res
, vol.67
, pp. 5531-5537
-
-
Agustsson, T.1
Rydén, M.2
Hoffstedt, J.3
Van Harmelen, V.4
Dicker, A.5
Laurencikiene, J.6
-
33
-
-
54049151993
-
Lipolysis - Not inflammation, cell death, or lipogenesis - Is involved in adipose tissue loss in cancer cachexia
-
M. Rydén, T. Agustsson, J. Laurencikiene, T. Britton, E. Sjölin, B. Isaksson, and et al. Lipolysis - not inflammation, cell death, or lipogenesis - is involved in adipose tissue loss in cancer cachexia Cancer 113 2008 1695 1704
-
(2008)
Cancer
, vol.113
, pp. 1695-1704
-
-
Rydén, M.1
Agustsson, T.2
Laurencikiene, J.3
Britton, T.4
Sjölin, E.5
Isaksson, B.6
-
34
-
-
84858021383
-
Muscle function, physical performance and body composition changes in men with prostate cancer undergoing androgen deprivation therapy
-
T.W. Storer, R. Miciek, and T.G. Travison Muscle function, physical performance and body composition changes in men with prostate cancer undergoing androgen deprivation therapy Asian J Androl 14 2012 204 221
-
(2012)
Asian J Androl
, vol.14
, pp. 204-221
-
-
Storer, T.W.1
Miciek, R.2
Travison, T.G.3
-
35
-
-
79851506306
-
Increase in visceral and subcutaneous abdominal fat in men with prostate cancer treated with androgen deprivation therapy
-
E.J. Hamilton, E. Gianatti, B.J. Strauss, J. Wentworth, D. Lim-Joon, D. Bolton, and et al. Increase in visceral and subcutaneous abdominal fat in men with prostate cancer treated with androgen deprivation therapy Clin Endocrinol (Oxf) 74 2011 377 383
-
(2011)
Clin Endocrinol (Oxf)
, vol.74
, pp. 377-383
-
-
Hamilton, E.J.1
Gianatti, E.2
Strauss, B.J.3
Wentworth, J.4
Lim-Joon, D.5
Bolton, D.6
-
36
-
-
84881110779
-
Sarcopenia and change in body composition following maximal androgen suppression with abiraterone in men with castration-resistant prostate cancer
-
C. Pezaro, D. Mukherji, N. Tunariu, A.M. Cassidy, A. Omlin, D. Bianchini, and et al. Sarcopenia and change in body composition following maximal androgen suppression with abiraterone in men with castration-resistant prostate cancer Br J Cancer 109 2013 325 331
-
(2013)
Br J Cancer
, vol.109
, pp. 325-331
-
-
Pezaro, C.1
Mukherji, D.2
Tunariu, N.3
Cassidy, A.M.4
Omlin, A.5
Bianchini, D.6
|